Back to Journals » Drug Design, Development and Therapy » Volume 11

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines

Total article views   Abstract views HTML views PDF downloads Totals
8,082 Dovepress* 6,781 673+ 1,171 7,454
PubMed Central* 0 628 254 628
Totals 6,781 1,301 1,425 8,082
*Since 3 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 2 3

View citations on PubMed Central and Google Scholar